Skip to content
Menu

Kymera Therapeutics, Inc. KYMR

Full chart Compare
Set alert

Price alert · KYMR

All alert types
119.39 USD -1.74 (-1.44%)

Regular-session close

119.39 0.00 0.00%

After hours · Nov 19, 4:39 PM ET

117.65 Day range 122.47
63.69 52-week range 142.92
YTD
+53.44%
1 year
+84.19%

Revenue & Expenses

Revenue Profit Costs
Other Income$38.00MGross Profit$39.20MNet Loss$311.40MExpenses$388.60MSelling, General & Admin$68.20MResearch & Development$316.60MOther Operating Expenses$3.80MRevenue$39.20M

Latest period ending Dec 31, 2025 · select a line to chart its full history

KYMR annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
39.21M47.07M78.59M46.83M72.83M
39.21M47.07M78.59M46.83M72.83M
-349.40M-261.63M-165.53M-161.26M-100.53M
-311.35M-223.86M-146.96M-154.81M-100.22M
-3.69-2.98-2.52-2.87-2.09
KYMR annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
362.81M126.05M115.78M74.53M54.09M
1.74B978.03M575.76M603.13M605.90M
163.15M142.42M180.79M112.98M146.27M
82.25M87.76M84.67M17.34M17.96M
1.58B835.62M394.97M490.15M459.64M
KYMR annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-232.89M-194.50M-102.83M-153.09M-128.95M
-521.06M-404.08M139.89M20.52M-99.83M
990.71M608.85M4.19M153.00M250.28M
-1.45M-12.84M-34.48M-2.84M-1.60M
236.76M10.27M41.25M20.43M21.50M